Neuralink vs Replit
Side-by-side equity comparison for employees weighing offers at Neuralink or Replit. Valuations, funding history, headcount growth, and secondary-market context.
| Neuralink | Replit | |
|---|---|---|
| Latest valuation | $10B | $9B |
| Latest round | Series D | Series C |
| Round date | November 2024 | April 2024 |
| Total raised | $680M | $222M |
| Founded | 2016 | 2016 |
| Headquarters | Fremont, CA | San Francisco, CA |
| Employees | 628 | 381 |
| Employee YoY growth | +19% | +143% |
| Primary industry | Healthcare & Biotech | Artificial Intelligence |
| Secondary-market price | — | $258.39 |
| Base-case equity multiple | 1x | 1x |
| Upside equity multiple | 1x | 1x |
| Lead investors | Founders Fund, GV (Google Ventures) | Andreessen Horowitz, Coatue Management |
| Status | private | private |
Overview
Neuralink develops implantable brain-computer interfaces designed to enable people with paralysis to control digital devices with their thoughts.
Replit is a browser-based IDE and cloud development platform that enables collaborative coding, app deployment, and AI-assisted software development.
Why we compare these
Neuralink and Replit both appear on Sara's List 2024 .
If you're evaluating offers at either one, the equity math depends on more than the headline valuation — dilution, strike price, time to liquidity, and concentration risk all matter. Use our equity compensation calculator and exit calculator to model your own numbers.